Every successful RNA-Seq experiment starts with a thorough and meticulous experimental plan. Designing the experiment is key and one of the main challenges for RNA sequencing. The potential of the
RNA sequencing (RNA-Seq) is a powerful tool that can be applied at various stages of the drug discovery and development workflow, from target identification to studying drug effects, mode-of-action, and
Next generation sequencing (NGS) has significantly advanced omics research, enabling high-throughput sequencing of DNA and RNA at unprecedented scale and depth offering a powerful tool to unravel the genetic basis
Today’s scientific landscape for drug discovery is extremely fast-paced: new technologies emerge constantly accelerating discoveries. Time is of the essence and researchers are seeking innovative ways to integrate more complex
Small molecule drugs, or low molecular weight compounds, are used as therapeutics to modulate physiological processes to treat or prevent diseases. The discovery of novel small molecule drugs is one
Traditional drug discovery often relies on single endpoint assays using visual markers, which can be challenging to quantify and limited in their ability to capture the complexity of biological systems.
In our previous Blog, we explored the importance and applications of RNA-Seq for plant transcriptomics and crop sciences. Even though analyzing a plants transcriptome can shed light on regulatory mechanisms,
Gene expression studies are becoming an important tool for plant breeding and agricultural biotechnology. For example, RNA-Seq has been used to identify differences in gene expression between domesticated grains and
Plants are primary producers and thus build the foundation of most of Earth’s ecosystems. Green plants utilize solar energy to fix inorganic carbon into organic carbohydrates providing basic food sources
Table of Content FFPE Transcriptomics Offers Valuable Insights into Diseases 3′ mRNA-Seq vs Whole Transcriptome RNA-Seq 3′ mRNA-Seq is Ideal for Expression Profiling Whole Transcriptome RNA-Seq for Isoform and Biomarker
Lexogen GmbH
Campus Vienna Biocenter 5
1030 Vienna, Austria
Telephone:
+43 (0) 1 345 1212
Sales support:
+43 (0) 1 345 1212-42
Technical support:
+43 (0) 1 345 1212-41
Working hours: 9:00 – 17:00 (CET)
Fax: +43 (0) 1 345 1212-99
Email: info@lexogen.com
Company number: FN 297318 h
VAT number: ATU63622048
Lexogen, Inc.
51 Autumn Pond Park
Greenland, NH 03840, US
Telephone:
+1-603-431-4300 ext.0
+1-877-Lexogen
(+1-877-539-6436) ext. 0
Sales inquiries:
Northeast: +1-312-978-6413
Southeast: +1-615-968-3325
Northwest: +1-415-726-4318
Southwest: +1-520-934-0678
Technical support:
+1-949-767-1631
(Working hours: 9:00 – 17:00 (EST))
+1-603-498-1666
(Working hours: 7:30 – 15:30 (CST))
Fax: +1-603-431-4333
Lexogen Newsletter
Subscribe to our mailing list to be among the first to get updates from us!
Copyright © 2026 Lexogen GmbH. All rights reserved | Impressum | Privacy Policy | Terms and Conditions | Whistleblowing
Product Short Description
PRICE
Product Short Description
PRICE
Product Short Description
PRICE
